Logo image of NOGN

NOGIN INC (NOGN) Stock Fundamental Analysis

NASDAQ:NOGN - US65528N2045 - Common Stock

0.061 USD
-0.05 (-45.58%)
Last: 12/21/2023, 8:00:02 PM
0.0526 USD
-0.01 (-13.77%)
After Hours: 12/21/2023, 8:00:02 PM
Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to NOGN. NOGN was compared to 28 industry peers in the Broadline Retail industry. Both the profitability and financial health of NOGN have multiple concerns. NOGN is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year NOGN has reported negative net income.
NOGN had a negative operating cash flow in the past year.
NOGN Yearly Net Income VS EBIT VS OCF VS FCFNOGN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 0 -20M -40M

1.2 Ratios

The Return On Assets of NOGN (-82.25%) is worse than 97.06% of its industry peers.
Industry RankSector Rank
ROA -82.25%
ROE N/A
ROIC N/A
ROA(3y)-25.04%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
NOGN Yearly ROA, ROE, ROICNOGN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 0 200 -200 -400

1.3 Margins

NOGN has a better Gross Margin (46.16%) than 61.76% of its industry peers.
In the last couple of years the Gross Margin of NOGN has declined.
The Profit Margin and Operating Margin are not available for NOGN so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 46.16%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-15.25%
GM growth 5YN/A
NOGN Yearly Profit, Operating, Gross MarginsNOGN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 0 20 -20 40 -40 60

More info and screens

0

2. Health

2.1 Basic Checks

NOGN does not have a ROIC to compare to the WACC, probably because it is not profitable.
NOGN has about the same amout of shares outstanding than it did 1 year ago.
Compared to 1 year ago, NOGN has a worse debt to assets ratio.
NOGN Yearly Shares OutstandingNOGN Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2M 4M 6M 8M 10M
NOGN Yearly Total Debt VS Total AssetsNOGN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 20M 40M 60M

2.2 Solvency

NOGN has an Altman-Z score of -7.66. This is a bad value and indicates that NOGN is not financially healthy and even has some risk of bankruptcy.
NOGN's Altman-Z score of -7.66 is on the low side compared to the rest of the industry. NOGN is outperformed by 82.35% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -7.66
ROIC/WACCN/A
WACC4.56%
NOGN Yearly LT Debt VS Equity VS FCFNOGN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 0 20M -20M 40M -40M 60M -60M

2.3 Liquidity

NOGN has a Current Ratio of 0.14. This is a bad value and indicates that NOGN is not financially healthy enough and could expect problems in meeting its short term obligations.
NOGN has a worse Current ratio (0.14) than 97.06% of its industry peers.
A Quick Ratio of 0.06 indicates that NOGN may have some problems paying its short term obligations.
NOGN's Quick ratio of 0.06 is on the low side compared to the rest of the industry. NOGN is outperformed by 97.06% of its industry peers.
Industry RankSector Rank
Current Ratio 0.14
Quick Ratio 0.06
NOGN Yearly Current Assets VS Current LiabilitesNOGN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 10M 20M 30M 40M 50M

More info and screens

4

3. Growth

3.1 Past

NOGN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 25.81%, which is quite impressive.
NOGN shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -39.39%.
NOGN shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 32.09% yearly.
EPS 1Y (TTM)25.81%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-120.69%
Revenue 1Y (TTM)-39.39%
Revenue growth 3Y32.09%
Revenue growth 5YN/A
Sales Q2Q%-48.01%

3.2 Future

The Earnings Per Share is expected to grow by 26.11% on average over the next years. This is a very strong growth
Based on estimates for the next years, NOGN will show a small growth in Revenue. The Revenue will grow by 2.87% on average per year.
EPS Next Y88.6%
EPS Next 2Y41.4%
EPS Next 3Y26.11%
EPS Next 5YN/A
Revenue Next Year-42.53%
Revenue Next 2Y-10.49%
Revenue Next 3Y2.87%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
NOGN Yearly Revenue VS EstimatesNOGN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M
NOGN Yearly EPS VS EstimatesNOGN Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 0 -10 -20 -30

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for NOGN. In the last year negative earnings were reported.
Also next year NOGN is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
NOGN Price Earnings VS Forward Price EarningsNOGN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
NOGN Per share dataNOGN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5

4.3 Compensation for Growth

A more expensive valuation may be justified as NOGN's earnings are expected to grow with 26.11% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y41.4%
EPS Next 3Y26.11%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for NOGN!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

NOGIN INC

NASDAQ:NOGN (12/21/2023, 8:00:02 PM)

After market: 0.0526 -0.01 (-13.77%)

0.061

-0.05 (-45.58%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustryBroadline Retail
Earnings (Last)11-22 2023-11-22/dmh
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners173.51%
Ins Owner Change0%
Market Cap688.60K
Analysts42.86
Price Target1.02 (1572.13%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-55.76%
Min EPS beat(2)-88.42%
Max EPS beat(2)-23.09%
EPS beat(4)1
Avg EPS beat(4)-47.28%
Min EPS beat(4)-88.42%
Max EPS beat(4)0.72%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-9.96%
Min Revenue beat(2)-16.37%
Max Revenue beat(2)-3.55%
Revenue beat(4)0
Avg Revenue beat(4)-10.35%
Min Revenue beat(4)-19.37%
Max Revenue beat(4)-2.13%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-60%
PT rev (3m)-60%
EPS NQ rev (1m)0%
EPS NQ rev (3m)45.79%
EPS NY rev (1m)-7.04%
EPS NY rev (3m)-7.04%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)1.5%
Revenue NY rev (1m)1.91%
Revenue NY rev (3m)1.91%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.01
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-6.12
EYN/A
EPS(NY)-0.02
Fwd EYN/A
FCF(TTM)-3.34
FCFYN/A
OCF(TTM)-3.28
OCFYN/A
SpS6.05
BVpS-8.46
TBVpS-8.93
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -82.25%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 46.16%
FCFM N/A
ROA(3y)-25.04%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-15.25%
GM growth 5YN/A
F-Score4
Asset Turnover1.44
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 65.24%
Cap/Sales 0.91%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.14
Quick Ratio 0.06
Altman-Z -7.66
F-Score4
WACC4.56%
ROIC/WACCN/A
Cap/Depr(3y)305.57%
Cap/Depr(5y)N/A
Cap/Sales(3y)2.31%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)25.81%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-120.69%
EPS Next Y88.6%
EPS Next 2Y41.4%
EPS Next 3Y26.11%
EPS Next 5YN/A
Revenue 1Y (TTM)-39.39%
Revenue growth 3Y32.09%
Revenue growth 5YN/A
Sales Q2Q%-48.01%
Revenue Next Year-42.53%
Revenue Next 2Y-10.49%
Revenue Next 3Y2.87%
Revenue Next 5YN/A
EBIT growth 1Y-59.49%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year48.07%
EBIT Next 3Y34.2%
EBIT Next 5YN/A
FCF growth 1Y-21.68%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-24.43%
OCF growth 3YN/A
OCF growth 5YN/A